Dermira (NASDAQ: DERM) April call option implied volatility is at 95, May is at 63; compared to its 52-week range of 28 to 261 following this morning's Phase IIb lebrikizumab data in atopic dermatitis. Call put ratio 2.4 calls to 1 put with focus on June 10 calls.